🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07601191
Starting soon Not applicable

AutoFUSE or First-Trimester Ultrasound Scan

NCT07601191 · tracked via the Priya Life Science China tracker
Sponsor
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase
Not applicable
Started
2026-06-01
Last updated
2026-05-22

Condition(s) studied

Fetus Disorder

Investigational drug(s) / intervention(s)

AutoFUSE systemTraditional ultrasound scan

AutoFUSE system: AutoFUSE is an AI-based intelligent image quality control system independently developed for first-trimester fetal ultrasound scan (FTFUS).

Traditional ultrasound scan: Traditional ultrasound scan means the standard clinical ultrasound examination performed by sonographers using routine manual operation to acquire predefined standard anatomical planes, without real-time AI assistance, automatic plane recognition, or automatic image quality assessment. All plane acquisition and quality evaluation are completed manually by the operator.

Study summary

The goal of this clinical trial is to validate the clinical application capabilities of AutoFUSE. The main questions it aims to answer are:

Does AutoFUSE reduce the time required to obtain standard planes in first-trimester ultrasound scan? Does AutoFUSE improve the accuracy of standard plane acquisition in first-trimester ultrasound scan? What safety outcomes occur in participants undergoing AutoFUSE-assisted ultrasound examination? Researchers will compare AutoFUSE-assisted ultrasound scan with standard clinical protocol (SCP) ultrasound scan to evaluate the efficacy and safety of AutoFUSE in clinical practice.

Participants will:

Undergo either AutoFUSE-assisted ultrasound scan or standard clinical ultrasound scan according to the study design.

Complete scheduled visits for examinations, data collection and follow-up. Provide information related to scan time, image quality and safety during the study.

Eligibility

Sex
FEMALE
Min age
—
Max age
—
Healthy volunteers
Accepted
Inclusion Criteria: ① Pregnant women undergoing fetal ultrasound examination. ② A singleton pregnancy with a live fetus between 11 and 13+6 weeks with complete outcomes. Exclusion Criteria: * Incomplete pregnancy outcome information. * Unexplained miscarriages. ③ Fetal death. * Pregnancies with significant maternal complications. * Multiple pregnancies.

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
Wuhan Union Hospital Wuhan Hubei
Zhongnan Hospital of Wuhan University Wuhan Hubei
Renmin Hospital of Wuhan University Wuhan Hubei

More Union Hospital, Tongji Medical College, Huazhong University of Science and Technology trials in China

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07601191 on ClinicalTrials.gov ↗ ← All trials in China